Regenxbio Inc (RGNX)

Stock-Based Compensation

$35.04M

TTM · Period ending: · USD

RGNX logo

RGNX Stock-Based Compensation

Latest reported$35.04M
RGNX TTM Stock-Based Comp ($319.00K → $35.04M)
High-resolution chart · PNG

RGNX stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regenxbio Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
35,043,000
34,643,000
34,563,000
35,730,000
36,616,000
37,398,000
38,463,000
37,259,000
37,594,000
38,663,000
40,267,000
41,337,000
41,363,000
41,194,000
40,788,000
40,542,000
40,031,000
29,696,000
28,816,000
27,235,000
25,536,000
33,852,000
31,949,000
31,243,000
30,370,000
29,153,000
26,854,000
24,865,000
22,186,000
19,068,000
16,641,000
14,551,000
12,803,000
11,305,000
10,605,000
9,809,000
8,903,000
8,076,000
7,031,000
5,893,000
5,412,000
4,391,000
2,921,000
2,158,000
1,030,000
395,000
319,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.